Company
Alector, Inc. (ALEC)
Standardized SEC financial data for Alector, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001653087 · NASDAQ · Biological Products, (No Diagnostic Substances).
Operating margin
-741.3%
Net margin
-679.2%
Revenue growth (YoY)
-79.1%
Return on equity
-466.3%
Free cash flow
-$184.1M
Debt / equity
0.33×
Current ratio
3.83×
EPS (diluted)
$-1.39
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $21.1M | $207.1M | $133.6M | $97.1M | $100.6M | $21.0M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $51.4M | $330.6M | $155.8M | $76.1M | $34.9M | $67.6M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$166.7M | $298.6M | -$20.3M | -$184.2M | -$229.9M | -$184.0M |
| Capital expenditures |
Get ALEC data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ALEC/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ALEC/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"